Tandem Dosing of Samarium-153 Ethylenediamine Tetramethylene Phosphoric Acid With Stem Cell Support for Patients With High-Risk Osteosarcoma

BACKGROUND: Samarium-153 ethylenediamine tetramethylene phosphoric acid ((153)Sm-EDTMP) is a radiopharmaceutical that has been used to treat osteosarcoma. The authors conducted a phase 2 study to test safety and response of high-risk osteosarcoma to tandem doses of (153)Sm-EDTMP and to determine cor...

Full description

Saved in:
Bibliographic Details
Main Authors: Loeb, David M., Hobbs, Robert F., Okoli, Amarachukwu, Chen, Allen R., Cho, Steve, Srinivasan, Senthamizhchelvan, Sgouros, George, Shokek, Ori, Wharam, Moody D., Scott, Tammy, Schwartz, Cindy L.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2991401/
https://ncbi.nlm.nih.gov/pubmed/20715156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25518
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items